LONDON, June 25 U.S. drugmaker AbbVie
declined to rule out a hostile bid for Shire on
Wednesday but said it was pushing hard for the London-listed
drugmaker to engage in talks, after its $46 billion takeover
approach was rejected.
Questioned by analysts if he might make a hostile bid, Chief
Executive Richard Gonzalez said on conference call: "We're not
willing to restrict our legal options here." He declined to
comment on what approach AbbVie might take if it went down a
Gonzalez stressed he wanted to engage with Shire's
management to better understand its upbeat drug sales forecasts,
adding he also planned to meet with Shire shareholders.
(Reporting by Ben Hirschler; editing by Kate Holton)